6 ALL ORAL THERAPY WITH SOFOSBUVIR + RIBAVIRIN FOR 12 OR 16...

Journal of Hepatology 2013 / 04 Vol. 58

6 ALL ORAL THERAPY WITH SOFOSBUVIR + RIBAVIRIN FOR 12 OR 16 WEEKS IN TREATMENT EXPERIENCED GT2/3 HCV-INFECTED PATIENTS: RESULTS OF THE PHASE 3 FUSION TRIAL

Nelson, D.R., Feld, J., Kowdley, K.V., Al-Assi, M.T., Lin, M., Mo, H., McNally, J., Brainard, D.M., Symonds, W.T., McHutchison, J.G., Patel, K., Gordon, S.C.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
58
Language:
english
Journal:
Journal of Hepatology
DOI:
10.1016/S0168-8278(13)60008-2
Date:
April, 2013
File:
PDF, 74 KB
english, 2013
Conversion to is in progress
Conversion to is failed